It plays a critical role in energy metabolism by transporting long-chain fatty acids into the mitochondria, where they are oxidized (burned) to produce energy
A human pharmacokinetic study reported a terminal half-life of approximately two hours and a brief episode of GH release
The false discovery rates for C3DC, C4, C10:1 and C10:2 were 0.172, 0.120, 0.064 and 0.139, respectively
Structural optimization: Further reduce IGFBP binding ability through site directed mutagenesis, or introduce transmembrane peptides to enhance tissue penetration
No noticeable side effects other than some PIP (which is weird because Ive injected plenty of times before)
Conclusion Retatrutide represents an important advancement in the evolution of incretin-based metabolic research